SCG CELL THERAPY PTE. LTD.
Last Updated: 13 Apr 2026
Established in Singapore, SCG Cell Therapy Pte Ltd (SCG) is a biotech company that leverages regional advantages in Singapore, China, and Germany to cover the entire value chain for drug research, discovery, manufacturing, clinical development, and commercialization. SCG specializes in developing novel immunotherapies for infectious diseases and their associated cancers, including Helicobacter pylori, human papillomavirus, and hepatitis B. The company's pipeline includes T cell therapies, antibodies, and therapeutic vaccines to prevent and cure these infections. SCG collaborates with leading scientists and researchers to bring innovative medical products and technologies to market.
Country of registration | Singapore |
Registration number | 201728785N |
Local SIC | |
Incorporation date | 9 Oct 2017 |
Company age | 8 years 7 months |
Official entity type | Private Limited Company |
No. of officers | 94 |
Contact
Address:
138 DEPOT ROAD, #04-02, Singapore 109683
Phone number:
Access Key Decision Makers
This is the legal entity page of SCG CELL THERAPY PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- SCG CELL THERAPYView MoreSingaporeEstablished in Singapore, SCG Cell Therapy Pte Ltd (SCG) is a biotech company that leverages regional advantages in Singapore, China, and Germany to cover the entire value chain for drug research, discovery, manufacturing, clinical development, and commercialization. SCG specializes in developing novel immunotherapies for infectious diseases and their associated cancers, including Helicobacter pylori, human papillomavirus, and hepatitis B. The company's pipeline includes T cell therapies, antibodies, and therapeutic vaccines to prevent and cure these infections. SCG collaborates with leading scientists and researchers to bring innovative medical products and technologies to market.
This is the legal entity page of SCG CELL THERAPY PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Auditor | NEXIA SINGAPORE PAC |
Revenue | < 1m |
Share Capital - Ordinary shares | SGD 55,653,988 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of SCG CELL THERAPY PTE. LTD.?
- Where is SCG CELL THERAPY PTE. LTD.'s headquarter?
- What is SCG CELL THERAPY PTE. LTD.'s contact number?
- What SCG CELL THERAPY PTE. LTD.'s spending power?
- Does SCG CELL THERAPY PTE. LTD. have a presence in the domain it operates in?